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        Introduction 
  Sphingolipids are important structural elements of cell mem-
branes and provide mechanical and chemical stability (  Acharya 
and Acharya, 2005  ;   Riezman, 2006  ;   Zeidan and Hannun, 2007  ; 
  Hannun and Obeid, 2008  ). They also serve specifi  c functions in 
cell  –  cell recognition and signaling (  English et al., 2002  ;   Futerman 
and Hannun, 2004  ;   Hla, 2005  ;   Zheng et al., 2006  ). Several 
intermediates of the sphingolipid metabolic pathway are known 
as second messengers that mediate processes such as angio-
genesis, cell growth, differentiation, and apoptosis (  Merrill, 2002;   
  Alvarez et al., 2007  ;   Haberkant et al., 2008  ;   van Meer et al., 
2008  ). Ceramide is a precursor for the synthesis of several 
sphingolipids. In addition to being an obligate intermediate in 
the de novo sphingolipid biosynthetic pathway, ceramide has 
been implicated as a mediator of stress responses, cell differen-
tiation, and apoptosis (  Hannun and Obeid, 2008  ). Its involve-
ment in apoptosis is clinically signifi  cant: many chemotherapeutic 
agents for cancer appear to induce ceramide-dependent apopto-
sis, and some of the associated enzymes and proteins, including 
ceramide transfer protein (CERT), are being investigated as 
targets for cancer therapies (  Ogretmen and Hannun, 2004  ; 
 Savtchouk et al., 2007 ;  Swanton et al., 2007 ;  Zeidan and Hannun, 
2007  ). Many of the fundamental questions pertaining to the 
study of ceramide and sphingolipid-mediated cell regulation re-
main unresolved. 
  Sphingolipids are vectorially synthesized in the cell. The 
de novo biosynthesis begins with the condensation of serine and 
C
eramide transfer protein (CERT) functions in the 
transfer of ceramide from the endoplasmic reticu-
lum (ER) to the Golgi. In this study, we show that 
CERT is an essential gene for mouse development and em-
bryonic survival and, quite strikingly, is critical for mito-
chondrial integrity. CERT mutant embryos accumulate 
ceramide in the ER but also mislocalize ceramide to the 
mitochondria, compromising their function. Cells in mu-
tant embryos show abnormal dilation of the ER and 
degenerating mitochondria. These subcellular changes 
manifest as heart defects and cause severely compromised 
cardiac function and embryonic death around embryonic 
day 11.5. In spite of ceramide accumulation, CERT mu-
tant mice do not die as a result of enhanced apoptosis. In-
stead, cell proliferation is impaired, and expression levels 
of cell cycle  –  associated proteins are altered. Individual 
cells survive, perhaps because cell survival mechanisms 
are activated. Thus, global compromise of ER and mito-
chondrial integrity caused by ceramide accumulation in 
CERT mutant mice primarily affects organogenesis rather 
than causing cell death via apoptotic pathways.
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lipids, require ceramide to be transported from the ER to the Golgi 
complex. Because ceramide is highly insoluble, an energy bar-
rier impedes the movement of ceramide from one membrane to 
another, and cells accumulate pools of ceramide in different 
a fatty acyl Co-A; a series of reactions follow that leads to the 
generation of ceramide in the ER (  Menaldino et al., 2003  ; 
  Hanada, 2006  ). The subsequent steps of sphingolipid biosynthe-
sis, including those of sphingomyelin and complex sphingo-
  Figure 1.       Isolation of CERT-deﬁ  cient (  Cert 
gt/gt    ) mice.   (A) The genomic organization of   Cert   is shown, and the location of the gene trap vector in the ES 
cell line RRF047 is depicted in the middle panel. This insertion results in truncation of the product within the pleckstrin homology (PH) domain of the CERT 
protein and results in a null or severely hypomorphic mutant. The insertion site was conﬁ  rmed by sequence analysis of PCR products. The third intron of   Cert   
is 26,177 bp long. The gene trap was inserted 18,394 nucleotides downstream of the 5     end of this intron. START, steroidogenic acute regulatory protein 
related. (B  –  D) The genotype of the   Cert 
+/gt     heterozygous intercross was conﬁ  rmed by genomic PCR across the insertion point (B), RT-PCR across exons 3 and 
4 (C), and Western analysis (D) as described in Materials and methods. +/+, wild type; +/    , heterozygous mutant;     /    , homozygous mutant. (E)   Cert 
gt/gt     
embryos have growth defects. The mutant embryos are smaller in size compared with wild type. These changes are obvious even in E7.5 embryos.     145 MITOCHONDRIAL DYSFUNCTION IN CERT MUTANT MICE   • Wang et al. 
(  Fig. 1, C and D  ). In contrast, CERT was clearly expressed in 
heterozygotes,   Cert 
+/gt     (+/   ), although the amount was lower 
than in the wild type,   Cert 
+/+     (+/+). Because the expression of 
the inserted     -galactosidase gene is under the control of the 
endogenous   Cert   promoter, we expected     -galactosidase to be 
expressed in all of the tissues that normally express CERT. 
    -Galactosidase staining of embryonic day 9.5 (E9.5) embryos 
showed strong staining in homozygous mutant embryos, in-
termediate staining in heterozygotes, and none in wild-type 
embryos (Fig. S1 A, available at http://www.jcb.org/cgi/content/
full/jcb.200807176/DC1). Sections through homozygous mu-
tant embryos showed ubiquitous expression of CERT (Fig. S1 B), 
which was detectable between E8.5 and E10.5 by Western 
blotting (not depicted). 
    Cert 
gt/gt     is an early embryonic lethal 
mutation 
  Genotypic analysis of   >  500 live-born progeny from hetero-
zygote intercrosses revealed that 35% were wild type, 65% were 
heterozygous, and none were homozygous mutant (Table I), in-
dicating that the   Cert 
gt/gt     mutation is a recessive embryonic le-
thal trait. Heterozygous mice,   Cert 
+/gt    , were viable, fertile, and 
morphologically identical to wild-type   Cert 
+/+     littermates.  To 
determine the developmental stage at which the   Cert 
gt/gt     fetuses 
die, embryos derived from   Cert 
+/gt     intercrosses were genotyped 
at different stages of gestation. We noticed several   Cert 
gt/gt     em-
bryos degenerating and beginning to be absorbed at E11.5. 
Moreover, between E7.5 and E10.5, all three genotypes were 
present in the expected Mendelian ratio (1:2:1; although the 
size of the homozygotes appeared somewhat reduced through-
out this time;   Fig. 1 E   and Table I). Therefore, we concluded 
that   Cert 
gt/gt     embryos die around E11.5. 
  We probed for molecular and cellular links between the 
observed defects and Cert  ’  s function. Therefore, we measured 
the sphingolipids in wild-type and mutant E10.5 embryos 24 h 
before the mutant embryos begin to die. 
  Sphingolipid metabolism is defective 
in   Cert 
gt/gt     mutant embryos 
  The sphingomyelin and ceramide levels in tissue extracts of 
E10.5 wild-type and mutant littermates were measured using 
nonpolar liquid chromatography (LC), electrospray ionization 
(ESI), and single reaction monitor (SRM) tandem mass spec-
trometry (MS) as described in Materials and methods (  Han and 
subcellular compartments. Recently,   Hanada et al. (2003)   dem-
onstrated that CERT, a member of the signal transduction and 
activation of the RNA family of proteins, is responsible for the 
bulk of the ceramide transport from the ER to the Golgi com-
plex. It localizes to the ER and the Golgi complex. CERT has 
three functional domains known to be involved in ceramide 
transport. An amino-terminal pleckstrin homology domain rec-
ognizes phosphatidylinositol 4-phosphate and targets CERT to 
the Golgi. An FFAT motif near the middle of the molecule is 
thought to interact with vesicle-associated membrane protein  –
  associated protein to recruit CERT to the ER (  Kawano et al., 
2006  ). The C-terminal steroidogenic acute regulatory protein  –
  related domain extracts ceramide from the ER membrane 
(  Fig. 1 A  ;   Hanada et al., 2003  ). 
  In this study, we evaluated the in vivo role of CERT in a 
mouse line lacking a functional   Cert   gene. We found that CERT 
is essential for embryonic survival, at least in part because of 
defects in proliferation and organogenesis with underlying ER 
and mitochondrial defects. Strikingly, this study also suggests 
that defects in the sphingolipid biosynthetic pathway that lead 
to ceramide accumulation can cause severe developmental dis-
ruption without inducing apoptosis. 
  Results 
  Generation of   Cert 
gt/gt     mice 
  The mouse   Cert   gene is on chromosome 13 and is encoded 
by 18 exons. The transcript has a short and a long form, with 
the short form containing 2,668 bp and the long form con
taining 2,746 bp. The respective proteins contain 624 and 598 
amino acids. To generate a mouse mutant of   Cert   (affecting 
both forms), we used the gene trap embryonic stem (ES) cell 
line RRF047 from BayGenomics (  Stryke et al., 2003  ). We ob-
tained the ES cell line and confi  rmed the insertion of the gene 
trap vector (pGT2Lxf) by RT-PCR and sequencing (  Fig. 1 A  ). 
The vector carries a splice acceptor sequence upstream of a 
galactosidase reporter gene,      -geo   (a fusion of    -galactosi-
dase and neomycin phosphotransferase II). A PCR genotyping 
strategy differentiated the mutant and wild-type alleles from 
DNA extracted from embryos (  Fig. 1 B  ). The deleted allele was 
null or severely hypomorphic because embryos homo    zy gous 
for this allele,   Cert 
gt/gt     (labeled    /    in fi  gures) embryos, did 
not generate full-length RNA as determined by RT-PCR, and 
there was little or no CERT detectable by Western analysis 
  Table I.       Genotypic analysis of offsprings from   Cert 
+/        intercrosses   
Stage Genotype Absorption Total
+/+ +/       /   
Newborn 195 (35%) 361 (65%) 0 NA 556
E7.5 5 8 4 NA 17
E8.5 11 19 10 NA 40
E9.5 26 32 12 NA 70
E10.5 25 44 22 5 91
E11.5 16 39 3 21 79
E12.5  –  14.5 11 21 0 9 41
NA, not applicable.JCB • VOLUME 184 • NUMBER 1 • 2009  146
amide level were lower than normal in the Golgi complex and 
the plasma membrane and higher than normal in the ER. There-
fore, we measured the ceramide levels in these organelles from 
E10.5 wild-type and mutant embryos by MS. In the plasma 
membrane, the levels of ceramides were reduced in the mutant; 
the ER of the   Cert 
gt/gt     embryos had twice as much ceramide as 
in the ER of age-matched   Cert 
+/+     wild-type controls (  Fig. 2, 
C and D ; Fig. S1 C shows minimal contamination of ER by mito-
chondria and vice versa). The total hexosylceramide (gluco-
sylceramides and galactosylceramides) content was lower in 
extracts of   Cert 
gt/gt     embryos compared with those of   Cert 
+/+    
wild-type controls (Table S1). 
 A   Drosophila melanogaster   mutant lacking a functional 
CERT protein is defective in sphingolipid metabolism, and stud-
ies in mammalian tissue culture cells indicate that the biosynthe-
sis of sphingomyelin is compromised when cells lacking CERT 
Gross, 2005  ;   Merrill et al., 2005  ). The d-18 sphingolipids are 
the predominant species in mammals, and, therefore, we fo-
cused on the sphingomyelin and ceramides of this series. The 
total sphingomyelin level was     2,490   ±   55 pmol/mg of protein 
in the wild-type embryos but only 1,044   ±   45 pmol/mg of pro-
tein in the homozygous mutants, a decrease of     58% (  Fig. 2 A  ). 
The breakdown of the individual species of the d-18:1 series 
from C-12 to C-26 is presented in Table S1 (available at http://
www.jcb.org/cgi/content/full/jcb.200807176/DC1). Surpris-
ingly, the total ceramides were not signifi  cantly different be-
tween the wild-type and mutant embryos (  Fig. 2 B  ). The total 
ceramide levels for the d-18:1 series in wild-type embryos was 
395   ±   11 pmol/mg of protein; in the mutant it was 413   ±   9 pmol/
mg of protein. Because ceramide transport from the ER to the 
Golgi is compromised in the CERT mutants, the wild-type lev-
els of total ceramide in the mutant could be explained if the cer-
  Figure 2.       Sphingolipid metabolism is dis-
rupted in   Cert 
gt/gt     embryos.   The total cell and 
plasma membrane sphingomyelins and cer-
amides were estimated in E10.5   Cert 
+/+     (+/+) 
and   Cert 
gt/gt     (    /    ) embryos as described 
under Materials and methods. (A) The total 
sphingomyelin levels are decreased in mutant 
embryos. (B) The total cellular ceramides are 
indistinguishable between the mutant and the 
wild type. (C) The plasma membrane ceramides 
are decreased in the mutant embryos. (D) CERT 
deﬁ  ciency and lack of ceramide transfer out 
of the ER cause increased ceramide levels by 
200% in the ER. (E) The plasma membrane 
sphingomyelins are decreased by 52% in the 
CERT mutant embryos. (F) Plasma membranes 
were prepared by density gradient centrifugation 
using Opti-prep, and membrane ﬂ  uidity was mea-
sured. No signiﬁ   cant differences were found 
in the ﬂ  uidity of plasma membrane between 
the wild type and the mutant. Error bars indi-
cate standard deviation.     147 MITOCHONDRIAL DYSFUNCTION IN CERT MUTANT MICE   • Wang et al. 
ically die. Although not as abundant as at E10.5, ER engorge-
ment, vesiculation, and mitochondrial changes were visible in 
the E9.5 embryos in differentiating cells of both the optic cup 
and the heart, including the myocardial cells (Fig. S3, available 
at http://www.jcb.org/cgi/content/full/jcb.200807176/DC1). 
  Chronic ER stress in   Cert 
gt/gt     embryos 
  The morphological features of   Cert 
gt/gt     mutant cells are remi-
niscent of cells undergoing ER stress. ER stress manifests in 
cells as ER proliferation, dilation, and vesiculation (  Scheuner 
and Kaufman, 2008  ). ER distension is a hallmark for cells that 
have defective protein folding in the ER lumen and is observed 
in response to the pharmacological induction of ER stress 
(  Ermonval et al., 1997  ;   Umebayashi et al., 1997  ;   Scheuner et al., 
2005  ). The ER is responsible for the synthesis of roughly a 
third of the proteins generated in a cell. Several hundred pro-
teins, including those involved in lipid biosynthesis, are up-
regulated when the unfolded protein response (UPR) signaling 
pathway is activated in yeast upon ER stress (  Travers et al., 
2000  ;   van Anken and Braakman, 2005  ). It has become increas-
ingly clear that components of the UPR are also up-regulated 
during development and differentiation in animals (  Reimold 
et al., 2000  ;   Bertolotti et al., 2001  ;   Zhang et al., 2005  ). The de-
fective transport of ceramide in vivo may therefore stress the 
ER and affect the viability of the cell and of the organism as a 
whole. Although it has been proposed that the accumulation of 
ceramide in the ER could cause stress, this has not been dem-
onstrated experimentally. 
  We used Western blot analysis to compare the steady-state 
levels of a panel of proteins implicated in the ER stress response, 
i.e., BiP, protein disulfi  de isomerase (PDI), IRE1-   ,  protein  ki-
nase  –  like ER kinase (PERK), eIF2-    , and C/EBP homologous 
protein, in E10.5   Cert 
+/+     and   Cert 
gt/gt     embryos (  Fig. 4 A  ). IRE1, 
PERK, and ATF6 are considered the proximal sensors of the 
UPR signaling cascade (  Malhotra and Kaufman, 2007  ;   Ron and 
Walter, 2007  ). These proteins collectively monitor the quality of 
the proteins synthesized in the ER. Activation of these three 
proteins either in isolation or in concert when unfolded proteins 
accumulate in the ER or the ER is subjected to stress is thought 
to initiate a transcriptional and translational program. Acute or 
low-level chronic stress of the ER will initiate protective re-
sponses, and the cells adapt by regulating the induction of chap-
erones and modulating the capacity of the ER to synthesize and 
properly fold new proteins. However, severe or persistently 
toxic ER stress that cannot be resolved can activate components 
of the cell death pathway. 
 We found that phosphorylated PERK protein was slightly 
lower in the extracts of   Cert 
gt/gt     than in   Cert/Cert   mice (  Fig. 4 A  ), 
and a proapoptotic downstream effector of phosphorylated 
PERK, C/EBP homologous protein, was unaffected (not de-
picted). IRE1-     levels were unchanged, and ATF6 was only 
slightly increased in the mutant embryos. However, some of 
the downstream components of the UPR pathway displayed 
signifi  cant changes: the protective ER chaperones calnexin, 
PDI, and ATF4 were increased in the   Cert 
gt/gt     cells (  Fig. 4 B  ). 
In addition, phosphorylated eIF2-    , which is implicated in 
cell cycle arrest and attenuates the translation of general proteins 
are grown in serum-free media (  Fukasawa et al., 1999  ;   Rao 
et al., 2007  ). In   Drosophila   CERT-null mutants, both ceramide 
phosphoethanolamine (CPE; sphingomyelin analogue) and ce-
ramide are decreased by  > 80%, and the decreased CPE in plasma 
membrane renders it more fl  uid and is responsible for the early 
death of these mutant fl  ies. Because the plasma membrane sphin-
gomyelin levels were decreased (  Fig. 2 E  ) in the   Cert 
gt /Cert 
gt    
embryos, albeit not as much as in   Drosophila   CERT  mutant 
(  dcert 
1    ) animals, we isolated and analyzed plasma membrane 
preparations from the   Cert 
+/+     and   Cert 
gt/gt     embryos.  There  were 
no signifi  cant differences in the fl  uidity of the plasma membrane 
between the wild-type and mutant cells (  Fig. 2 F  ). The   dcert 
1    
plasma membrane was used as the positive control (unpublished 
data). The decrease in sphingomyelin levels (58%) in   Cert 
gt/gt    
mutant embryos is less than that observed in   dcert 
1     fl ies and 
might not be low enough to render the plasma membrane fl  uid. 
  Therefore, our data suggest that sphingomyelin-associated 
membrane fl  uidity was not contributing to the observed defects 
in the CERT-defi  cient mice. Thus, we investigated whether the 
accumulation of ceramide in the ER of   Cert 
gt/gt     embryos could 
affect its structure and function and thus compromise the viabil-
ity of the cells. 
  ER and mitochondrial alterations 
in   Cert 
gt/gt     embryos 
  To evaluate whether the accumulation of ceramide affected the 
structure of the ER in the   Cert 
gt/gt     mutants, we examined sections 
from E8.5  –  10.5 embryos by transmission EM (TEM). Because 
the   Cert 
gt/gt     embryos exhibited cardiovascular defects (see sec-
tion   Cert 
gt/gt     mutants die around E11.5  …  ), we initially examined 
the hearts of E10.5 wild-type and mutant embryos. TEM analy-
sis of cells from the endocardial, muscular, and epicardial re-
gions showed proliferation, vesiculation, and even engorgement 
of the ER in the cells of the   Cert 
gt/gt     embryos (  Fig. 3  , top right). 
In many instances, these engorged ERs were accompanied by 
the accumulation of lipoid bodies in their vicinity ( Fig. 3 , bottom 
right, white arrow). Surprisingly, the mitochondria of   Cert 
gt/gt    
cells were abnormal as well, appearing pale and engorged (  Fig. 3  , 
middle and bottom). Many lacked cristae; several were under-
going gross structural changes and degenerating. 
  If indeed the CERT defi  ciency was responsible for these 
changes and CERT function is ubiquitous, we expect to see 
similar structural changes in other cell types of the developing 
embryo. To address this, we examined the cells of the develop-
ing optic cup, an easily identifi  able area of the developing em-
bryo, by TEM. Mitochondrial changes similar to the ones seen 
in the heart were predominant in these optic cup cells in the 
mutant E10.5 embryos (Fig. S2, available at http://www.jcb
.org/cgi/content/full/jcb.200807176/DC1). Although the ER and 
Golgi were the most visible structures in the wild-type   Cert 
+/+    
cells, indicating healthy activity, the mitochondria in the mutant 
cells could be seen degenerating in the vicinity of lipid-fi  lled 
structures. 
  To ascertain whether the compromised ER and mitochon-
dria initiated the abnormal development of the CERT-defi  cient 
embryos, we also examined cardiovascular and optic cup cells 
from E9.5 embryos; that is, 48 h before the mutant embryos typ-JCB • VOLUME 184 • NUMBER 1 • 2009  148
  Ceramide is increased in mitochondrial 
preparations of   Cert 
gt/gt     embryos 
  The accumulating ceramide causes ER stress, and the ceramide 
might be transferred to the mitochondria via recently discov-
ered regions of close contact between the ER and mitochondria 
(  Copeland and Dalton, 1959  ;   Ruby et al., 1969  ;   Morre et al., 
1971  ;   Meier et al., 1978  ;   Eggens et al., 1979  ;   Vance, 1991  ; 
  Rizzuto et al., 2004  ;   Franzini-Armstrong, 2007  ). Such a fi  nding 
would show a strong correlation between the altered sphingo-
lipid metabolism and the observed phenotypes in CERT mutant 
embryos. Therefore, we prepared mitochondrial preparations 
under ER stress, leading to adaptation, was signifi  cantly up-
regulated in the   Cert 
gt/gt     embryos (  Fig. 4 B  ). It is worth not-
ing that the phosphorylation of eIF2-     has been reported to 
increase signifi  cantly during the G2/M phase in Ba/F3 cells 
and at the G2/M boundary in human osteosarcoma cells (  Datta 
et al., 2005  ;   Tinton et al., 2005  ). These observations suggest 
that   Cert 
gt/gt     embryos are undergoing a state of chronic ER 
stress. The biochemical evidence correlating the structural al-
terations with functional changes in the ER prompted us to 
probe whether a similar situation existed in the mitochondria 
of   Cert 
gt/gt     embryos. 
  Figure 3.       EM evidence of ER and mitochon-
drial disorganization in   Cert 
gt/gt     embryos.   Cells 
from the three primary layers of the develop-
ing heart, namely endocardium, myocardium, 
and epicardium, of E10.5   Cert 
+/+     and   Cert 
gt/gt     
embryos were examined under an electron mi-
croscope. The panels on the left are from the 
  Cert 
+/+     (+/+) embryos, and the   Cert 
gt/gt     (    /    ) 
mutants are on the right. The black arrow 
shows a lipid-laden engorged rough ER (rer) 
in the endocardial layer of the mutant heart. 
The white arrows show lipid-laden structures 
found in the vicinity of swollen ER and mito-
chondria (m) found often in the mutant cells. 
The arrowheads show mitochondria under-
going degeneration with discontinuous outer 
and inner mitochondrial membranes in the myo-
cardial layer (middle). In the epicardial cells 
(bottom), the arrowheads depict swollen and 
pale mitochondria with ruptured inner and 
outer mitochondrial membranes in the mutant 
heart. The mitochondria in the mutant are gen-
erally swollen, pale, and have fewer cristae. 
n, nucleus; mf, muscle ﬁ  bers of the myocardial 
cells. Bars, 500 nm.     149 MITOCHONDRIAL DYSFUNCTION IN CERT MUTANT MICE   • Wang et al. 
  Cert 
gt/gt     embryos not only affected the ER but also had a strong ef-
fect on mitochondrial integrity and function. 
    Cert 
gt/gt     mutants die around E11.5 
as a result of cardiovascular insufﬁ  ciency 
  To correlate the underlying biochemical defects to the observed 
phenotype of the   Cert 
gt/gt     mutants, morphological assessment of 
embryos was performed. From the early head-fold stage (E7.5) 
to E10.5, the   Cert 
gt/gt     embryos were smaller than their wild-type 
  Cert 
+/+     counterparts (more the size of wild-type animals that 
were 0.5  –  1 d younger), although their gross appearance was 
similar to wild type (Fig. S1 A). To evaluate whether the growth 
defects began in early embryogenesis, we examined the out-
growth of   Cert 
gt/gt     blastocysts. E3.5 blastocysts were outgrown 
in ES media for 3 d, and no obvious developmental defect was 
found (Fig. S4, available at http://www.jcb.org/cgi/content/full/
jcb.200807176/DC1). The inner cell mass and the outgrowth of 
the polyploid trophoectoderm cells in all three cultures were 
easily distinguished. We also followed cell proliferation in the 
blastocysts by incubating them with BrdU after 3 d of out-
growth. No signifi  cant differences were noted among the out-
growths of the three genotypes (unpublished data). Therefore, 
the changes leading to the observed size difference in   Cert 
gt/gt    
mutants must manifest at a postimplantation stage. 
 CERT-defi  cient embryos obtained by caesarian section 
appeared normal at E8.5  –  10.5, although their growth was re-
tarded. Gross examination of the mutant embryos at E10.5 did 
not reveal any major developmental defects, except in the heart. 
The heart is the fi  rst functional embryonic organ, one of the fi  rst 
to differentiate and begin to function in the developing mouse 
embryo around E10.5 (  Sissman, 1970  ;   Challice and Viragh, 
1974  ). In all of the mutant embryos examined, the bilateral 
heart tubes had migrated between E8.5 and E9.0 to the midline 
and fused to form a single heart tube. Heartbeats were estab-
lished in the E10.5 mutants, indicating that they were all devel-
opmentally past E9.5. Closer examination of the dissected heart 
revealed that all of the   Cert 
gt/gt     embryos displayed a normal 
S-shaped loop. However, the truncus arteriosus region of the 
outfl  ow tract of some   Cert 
gt/gt     mutants (  Fig. 6 A  ) was thin, trans-
parent, and swollen, and the entire heart appeared swollen with 
thin and transparent walls in other embryos (  Fig. 6, A and B  , 
bottom right). In one embryo, the walls of the primitive ven-
tricle displayed a region of higher density (  Fig. 6 B  , top). 
from the wild-type   Cert 
+/+     and the mutant   Cert 
gt/gt     embryos and 
estimated ceramides in them. As shown in   Fig. 5 A  , the mito-
chondria of the mutants contained 1.5-fold more ceramide than 
those of the wild-type embryos. The lack of CERT function 
caused abnormal ceramide accumulation in the mitochondria of 
CERT-defi  cient embryos. 
  To determine whether mitochondrial functioning was 
compromised in the   Cert 
gt/gt     embryos, we evaluated the level of 
cytochrome   c   oxidase, the terminal enzyme of the oxidative 
phosphorylation cascade. Mitochondria were prepared using 
density gradient centrifugation, and the cytochrome   c   oxidase 
activity was measured. As shown in  Fig. 5 B , the activity of cyto-
chrome   c   oxidase was signifi  cantly lower in the mutant embryos 
than in wild-type embryos, indicating that the structural changes 
and lipoid degeneration observed in the CERT-defi  cient embryos 
resulted in compromised functioning of the mitochondria in 
these animals. Thus, the altered ceramide metabolism in the 
  Figure 4.         Cert 
gt/gt     embryos exhibit evidence of ER stress.   (A) Western blot 
analysis of cell extracts of E10.5 wild-type and   Cert 
gt/gt     embryos probed for 
proximal sensors such as phosphorylated PERK, IRE1-    , and ATF6 showing 
no or a slight increase in levels, a situation not different from cells in states 
of chronic stress. (B) Components of the UPR response implicated in the 
increased protein-folding efﬁ  ciency of the ER such as ATF4, PDI, and cal-
nexin were all increased in   Cert 
gt/gt     embryonic extract. The increased levels 
of phosphorylated eIF2-     are an indicator of the underlying ER stress. +/+, 
wild type;     /    , homozygous mutant.     
  Figure 5.       Increased ceramide content in mito-
chondria of   Cert 
gt/gt     compromises mitochon-
drial function.   (A) CERT deﬁ   ciency and lack 
of ceramide transfer out of the ER causes in-
creased ceramide levels in the mitochondria. 
(B) The cytochrome   c   oxidase activity, the 
terminal reaction in ATP generation, was de-
creased by more than half in the mutant mito-
chondria (  n   = 3; error bars are very small and 
indicate the standard error of the mean). +/+, 
wild type;     /    , homozygous mutant.     JCB • VOLUME 184 • NUMBER 1 • 2009  150
and sample preparation at room temperature, we never observed 
in them the extreme regurgitation of blood observed in the mu-
tant embryos. Furthermore, the mutant embryos were well past 
the 20-somite stage when embryonic hearts normally establish 
unidirectional blood fl  ow. 
  Histological analysis revealed an enlarged ventricular cav-
ity and thin walls (  Fig. 6 C  ). Closer inspection showed that the 
outfl  ow tract was enlarged and had thinner and weaker walls 
than the heterozygote or wild-type hearts, and the width of the 
acellular cardiac jelly between the inner endocardial cells and 
The contractions of the ventricles in the   Cert 
gt/gt     embryos  were 
obviously weaker than in normal embryos, and blood accumu-
lated in the ventricles of some animals (  Fig. 6 B  , bottom left). 
  Upon examination in utero, some   Cert 
gt/gt     embryos exhib-
ited complete regurgitation of the blood into the heart during di-
astole, a phenomenon not observed in any of the wild-type or 
heterozygous embryos (Videos 1 and 2, available at http://www
.jcb.org/cgi/content/full/jcb.200807176/DC1). Although in rare 
instances bradycardia and atypical contractions caused a partial 
backfl  ow of blood in a few wild-type hearts during dissection 
  Figure 6.       Cardiac defects in   Cert 
gt/gt     embryos.   
(A) Images of E10.5   Cert 
+/+     (+/+) and   Cert 
gt/gt     
(    /    ) embryos. The heads were removed to 
facilitate the observation of the heart. In gen-
eral, the mutant hearts were proportionately 
(relative to the size of the embryo) larger and 
thinner in the mutant compared with the wild 
type. (B, top) The same embryos in A were 
photographed from the other side to get a view 
of the left ventricle (LV), which, in this instance, 
appeared to have an area of increased density 
in the mutant embryo. The left bottom panel 
shows a mutant heart with accumulated blood 
in the left ventricle, and the panel on the right 
highlights the thin walls of the outﬂ  ow tract (oft) 
and the left ventricle in the   Cert 
gt/gt     hearts. 
(C) H  &  E sections of the wild-type (+/+) and 
mutant (    /    ) heart show the proportionately 
larger heart of the mutant with thin-walled ven-
tricles and the outﬂ  ow tracts. The inset shows a 
high magniﬁ  cation view of the outﬂ  ow tract. In 
this instance, the mutant outﬂ  ow tract is larger, 
thin walled, and increased the amount of the 
acellular cardiac jelly seen inside the cavity.     151 MITOCHONDRIAL DYSFUNCTION IN CERT MUTANT MICE   • Wang et al. 
fects of the   Cert 
gt/gt     embryos could be the result of apoptosis, 
cell death was measured by using TUNEL, as described in Ma-
terials and methods. As shown in   Fig. 7 E  , there was no differ-
ence in apoptotic cell death between mutant and wild-type 
embryos at E10.5, when all of the phenotypes described here 
were visible. The percentage of TUNEL-positive cells was de-
termined by counting cells in at least six areas of each embryo 
and comparing results of corresponding areas in wild-type 
  Cert 
+/+     and mutant   Cert 
gt/gt     embryos. Our results indicated that 
the cellular and molecular events that precede and contribute to 
heart failure do not include abnormal apoptotic cell death. We 
also did not observe cellular changes consistent with increased 
apoptosis among cells of the developing heart and optic cup of 
  Cert 
gt/gt     embryo (unpublished data) while examining them for 
the aforementioned subcellular morphology. 
  Activation of MAPK survival pathways 
and the inactivation of Akt/PKB and JNK 
signaling in   Cert 
gt/gt     embryos 
  Our data suggested that the accumulation of ceramide caused 
by CERT defi  ciency led to the activation of ER stress and caused 
mitochondrial dysfunction. How do CERT-defi  cient cells cope 
with these defects and survive at E10.5? To profi  le the response 
of the CERT-defi  cient cells at the molecular level, we performed 
immunoblotting for a panel of proteins, phosphorylated and/or 
nonphosphorylated, that are implicated in stress-activated cell 
survival responses and apoptosis. MAPK and Akt/PKB signal-
ing play critical roles in cell survival during stress. Therefore, 
we evaluated the steady-state levels of these proteins in wild-
type and mutant embryos by Western blotting. Surprisingly, the 
levels of the phosphorylated form of Akt were down-regulated 
in the mutant extracts compared with total Akt (  Fig. 7 D  ). 
  Although the difference in phosphorylated Akt could 
partly account for the cell cycle arrest/delay observed in CERT 
mutant cells, it could not fully explain the ability of the mutant 
cells to survive the ER stress. Therefore, we investigated the 
MAPK cell survival pathways. The MAPK signaling cascades 
are involved in stress-activated signaling responses. Extracellu-
lar signal-regulated kinase (ERK), JNK, and p38 MAPK are 
subgroups of the MAPK family. The dynamic balance between 
the activated ERK  –   and JNK  –  p38 signaling pathways is impor-
tant in determining cell survival versus apoptosis. As shown in 
  Fig. 8 A  , the ERK survival pathway was signifi  cantly activated 
in the mutants, but the JNK  –  p38 pathway was down-regulated. 
Therefore, cellular survival under ER stress in   Cert 
gt/gt     embryos 
involves a mechanism in which the ERK pathway is activated 
and the Akt, JNK, and p38 signaling pathways are suppressed. 
  A notable feature of the UPR is that it leads to the con-
comitant engagement of both adaptive and proapoptotic mole-
cules. Thus, we extended our analysis to see whether such a 
phenomenon had been initiated in the   Cert 
gt/gt     mice.  We  immuno-
blotted extracts from E10.5 embryos to look for the possible 
activation of cell death pathways (  Fig. 8 B  ). Surprisingly, the 
proapoptotic proteins Bax and Bak were signifi  cantly elevated 
in the   Cert 
gt/gt     embryos, and the antiapoptotic Bcl-2 and Bcl-x  L  
were down-regulated. It is worth noting that the Bcl-2 family 
proteins also play important roles in ER physiology and regulate 
the outer cardiomyocytes was also enlarged in many mutant 
hearts (  Fig. 6 C  , inset). In several mutant embryos, the ballooned 
and thin-walled heart chambers were so fragile that they were 
punctured during dissection, even with very gentle handling. 
  The combined gross and histological fi  ndings indicated 
that the   Cert 
gt/gt     embryos die around E11.5 from failure to es-
tablish a fully functional cardiovascular system. The non-
productive cardiac contractions indicated that there was a 
cardiac pump failure that caused venous dilation, which could 
lead to low blood pressure, systemic hypoxia, and eventual 
embryonic death. 
  Cell proliferation changes in   Cert 
gt/gt     
embryos 
  At the cellular level, the growth defects of the   Cert 
gt/gt     embryos 
could arise either from aberrant proliferation and differentiation 
or excessive cell death. Thus, we evaluated the proliferative po-
tential of   Cert 
gt/gt     embryonic cells by labeling dividing cells 
with BrdU (  Fig. 7 A  ), which is incorporated during the S phase. 
The percentage of cells that incorporated BrdU was calculated 
in four different areas of each animal. The mutants had BrdU-
positive indices that were signifi  cantly lower than those of wild-
type   Cert 
+/+     embryos (  Fig. 7 B  ). These results suggested that 
the cell cycle patterns of the   Cert 
gt/gt     embryos were aberrant, 
which could contribute to the observed defects in the growth 
and development of the mutant embryos. 
  To gain insight into the molecular changes affecting the 
cell cycle in the mutant embryos, we immunoblotted tissue ex-
tracts of E10.5 normal and mutant embryos for various cell 
cycle markers. As shown in   Fig. 7 C  , the levels of cyclin D1, a 
marker for G1 phase, and Cdc2, an essential cell cycle kinase 
and regulator of the G2/M transition, were decreased in the mu-
tant embryos (  Berthet and Kaldis, 2007  ;   Satyanarayana et al., 
2008  ). Moreover, the fraction of the inactive phosphorylated 
form of Cdc2 (Y15P-Cdc2) was higher in the mutant than in 
  Cert 
+/+     embryos, suggesting Cdc2 activity was lower in the 
  Cert 
gt/gt     embryos, a change that could delay the entry of cells 
into the G2/M phase. 
  Active Akt has been implicated in the regulation of car-
diac myocytes and the proliferation of cardiac progenitor cells 
(  Sussman, 2007  ). Therefore, we measured the Akt levels in the 
wild-type and mutant developing embryos. As shown in   Fig. 7 D  , 
we found that the level of phosphorylated Akt was down-regulated 
in the   Cert 
gt/gt     embryos, perhaps contributing, at least in part, to 
their decreased cell proliferation. Our fi  ndings show that the ex-
pression and regulation of key cell cycle proteins are affected in 
the mutant embryos, although further detailed studies will be 
required to understand the complexity of the deregulation. Fur-
thermore, these results suggest that the   Cert 
gt/gt     proliferation  de-
fi  ciency occurs via a mechanism that is directly or indirectly 
linked to S- and M-phase entry. 
  Defects in   Cert 
gt/gt     embryos are not caused 
by increased apoptosis 
  The complex pathways involved in sphingolipid metabolism 
have been implicated in the regulation of apoptosis. To learn 
whether the excessive loss of tissue and the developmental de-JCB • VOLUME 184 • NUMBER 1 • 2009  152
in the mitochondria (  Fig. 8 C  ), supporting a nonmitochondrial 
role for the increased Bax protein. Also, the total level of cyto-
chrome   c  , a key molecule released from mitochondria into the 
cytosol in the mitochondrial apoptotic pathways, was clearly 
decreased in the   Cert 
gt/gt     embryos. In contrast, the level of apop-
tosis-induced factor was not affected (  Fig. 8 C  ). Because the 
mitochondrial morphogenesis (  Karbowski et al., 2006  ). Bax 
and Bak were recently shown to act not only as essential gate-
way proteins to cell death pathways operating at the mitochon-
dria but also to relocate to the ER to function in the regulation 
of UPR (  Wei et al., 2001  ;   Hetz et al., 2006  ;   Oakes et al., 2006  ). 
Bax accumulated in postmitochondrial supernatant rather than 
  Figure 7.       Growth and cell cycle defects without increased apoptosis in   Cert 
gt/gt     mutant embryos.   (A) Pregnant mice were injected with BrdU 1 h before 
dissection, and E10.5 embryos were dissected, genotyped, and stained for BrdU uptake as described in Materials and methods. Four of the areas chosen 
for counting the fraction of dividing cells are shown in the panels to the right. (B)   Cert 
gt/gt     embryos showed a lower fraction of BrdU-positive cells, indicating 
a slower rate of cell division in these mutant embryos. Error bars indicate standard deviation;   n   = 4. (C) Western blot analysis for some of the components 
of the cell cycle in   Cert 
+/+     (+/+) and   Cert 
gt/gt     (    /    ) embryos. (D) Phosphorylated Akt levels are decreased in   Cert 
gt/gt     embryos. (E) TUNEL staining of 
E10.5 wild-type and mutant embryos. Insets show boxed areas at higher magniﬁ  cation. There were no signiﬁ  cant differences in the proportion of dying 
cells between the wild-type and mutant embryos. Note that the wild-type embryos are large compared with the mutant and, therefore, were photographed 
twice to include the upper and the lower halves of the embryo. The composites are shown in A and E.     153 MITOCHONDRIAL DYSFUNCTION IN CERT MUTANT MICE   • Wang et al. 
these organisms stem not only from the differences in their de-
velopmental programs but also from differences in the under-
lying biochemical changes accompanying the CERT defi  ciency. 
  CERT mutants in both organisms have decreased sphin-
gomyelin levels (CPE in   Drosophila  ). Although there is a four-
fold decrease in the   Drosophila   adult, there is slightly more than 
a twofold decrease in the mutant mouse embryos. This is proba-
bly because the mouse embryos, unlike   Drosophila ,  developed 
within the uterus of a heterozygous mother, where sphingo-
myelin, a component of plasma lipoprotein fraction, can be deliv-
ered to the developing embryos through the amniotic fl  uid (  Liu 
et al., 1992  ;   Subbaiah and Liu, 1993  ). In an analogous situation, 
CERT-defi  cient CHO cells (Ly-A), when grown in the presence 
of serum, do not show changes in steady-state sphingomyelin 
levels because they can incorporate the metabolites from the 
medium (  Fukasawa et al., 1999  ;   Hanada et al., 2003  ). However, 
experimental evidence for this explanation of the differences in 
sphingomyelin levels is lacking. In any case, the effects of the 
decrease differ in mice and   Drosophila  : the very signifi  cant de-
crease in the CPE levels of   Drosophila   CERT  mutants  affects 
plasma membrane fl  uidity and initiates oxidative stress; the 
smaller decrease in sphingomyelin in the CERT-defi  cient mouse 
embryo did not alter plasma membrane fl  uidity. In   Drosophila , 
total ceramide levels decrease by 80%, whereas they remain un-
changed in mice. However, in the mouse embryo, a 200% in-
crease in ceramide levels in the ER instigates a series of 
pathophysiological changes and ultimately causes early embry-
onic lethality. 
  The most important fi  nding of this study is the impact of 
defi   cient ceramide transport on mitochondrial structure and 
function in mice. Mass spectrometric data indicated increased 
levels of ceramide in the mitochondria and ER, and electron 
micrographic pictures showed progressive degeneration of the 
mitochondria. The changes in ceramide levels and in the struc-
ture and function of mitochondria that accompany the CERT 
defi  ciency in mice support the idea that ceramide is normally 
directly transferred from the ER to the mitochondria. Studies 
have demonstrated a close functional link between the ER and 
  Cert 
gt/gt     embryos showed no sign of apoptosis, it was clear that 
several factors infl  uenced the survival of the CERT-defi  cient 
cells, although the compensation was not vigorous enough to 
overcome the growth delays imposed on cells under chronic ER 
stress (  Rutkowski et al., 2006  ). 
  Our data suggested that although activators of apoptosis 
were initiated in the CERT-defi  cient cells, the effectors were not 
deployed to execute apoptosis. One reason for the lack of de-
ployment could be the low level of cytochrome   c   in the mutant 
embryos. In addition, the predominant activation of proteins in 
the cell survival pathways of the MAPKs could contribute to 
this effect. We have also confi  rmed that CERT defi  ciency does 
not inherently compromise the apoptotic potential of the mutant 
cells. Primary mouse embryonic fi  broblasts (MEFs) can be de-
rived and cultured from the mutant E9.5 embryos. Although 
they are slightly growth inhibited compared with similarly derived 
wild-type MEFs, they are capable of undergoing actinomycin 
D  –  induced apoptosis ex vivo (Fig. S5, available at http://www
.jcb.org/cgi/content/full/jcb.200807176/DC1). A very high ADP/
ATP charge ratio, an indicator of the inability to undergo apop-
tosis, was also not a contributing factor in the mutant embryos 
because these ratios were similar in the wild-type and the mu-
tant embryos. Also, total ATP levels were comparable between 
the wild-type and mutant embryonic extracts, implying that in-
suffi  cient ATP was not responsible for the failure to undergo apop-
tosis (unpublished data). 
  Discussion 
  In this study, we showed that CERT, a protein that transports cer-
amide from the ER to the Golgi, is essential for survival in mice. 
Mice lacking CERT die at E11.5 because of cardiac abnormali-
ties manifesting as a result of underlying structural and func-
tional defects in ER and mitochondria. The in vivo signifi  cance 
of ceramide transfer from the ER to the Golgi was studied re-
cently using a   Drosophila   model (  Rao et al., 2007  ). Flies lacking 
a functional CERT protein are viable and fertile but die prema-
turely as a result of accelerated aging. The different outcomes in 
  Figure 8.       Cell survival pathways are activated in E10.5   Cert 
gt/gt     embryos.   (A) Components of the cell survival pathway p42/44 ERK are strongly activated 
in the mutant, whereas MAPK components that mediate stress-mediated response are suppressed. SAPK, stress-activated protein kinase. (B) Components of 
the apoptotic machinery such as Bak and Bax that also have roles in mediating UPR are activated, whereas antiapoptotic components Bcl-2 and Bcl-x are 
down-regulated. (C) The total cytochrome   c   levels in   Cert 
gt/gt     embryos are decreased signiﬁ  cantly in the mutant embryos. Although most of the cytochrome   c   
is in the mitochondria in the wild type, in the mutant we see it in both cytosol (C) and mitochondria (M). Also, the increased Bax in   Cert 
gt/gt     embryos is in 
the cytosol, whereas mitochondrial levels seem unaffected. AIF, apoptosis-induced factor.     JCB • VOLUME 184 • NUMBER 1 • 2009  154
tion in sphingolipid metabolism, it is present in all cells and tis-
sues. Perhaps surprisingly, although none of the cells in the 
  Cert 
gt/gt     mice could transport ceramide, they could still divide at 
a compromised rate, and they progressed through a nearly nor-
mal developmental program until about E10  –  11.5. 
  This stage is a remarkable period in mouse development. 
Beginning around E8 and lasting until around E11.5, there is a 
sudden increase in the growth and complexity of the embryo 
(  Viragh and Challice, 1973  ). The sudden shift in the pace of divi-
sion and differentiation imposed on the CERT mutant cells at 
these stages apparently outstrips the ability of these compromised 
cells to respond to developmental signals. This notion is partly 
supported by our EM data that showed at E9.5 the beginnings of 
changes to the mitochondria and ER that were much more obvi-
ous at E10.5. That the animals died of cardiovascular defects is 
very reasonable in this context. During the 24-h window between 
E8.0 and E9.0, the linear dimensions of the heart increase four- to 
fi  vefold, which apparently pushed the mutant cells beyond their 
capacity to adapt. Because a functional circulatory system is an 
early requirement for survival and growth, its developmental fail-
ure resulted in early death attributable to the lack of CERT func-
tion. However, the underlying pathology existed in all of the 
embryonic cells, as indicated by the similar mitochondrial and 
ER changes observed in the cells of the developing eye. 
  Our study clearly demonstrates that manipulation of sphin-
golipid fl  ux in vivo and the consequent accumulation of cer-
amide within cellular compartments do not necessarily end in 
apoptotic cell death. In the present study, it leads to defects in 
cell cycle and differentiation caused by the stress imposed on 
the ER and mitochondria. In sum, our combined approach has 
identifi  ed the essential role of CERT in mammalian embryo-
genesis and provided molecular insight into the role of the 
de novo sphingolipid biosynthetic pathway in infl  uencing the 
ER-dependent structure/function of mitochondria. 
  Materials and methods 
  Generation of CERT knockout mice 
  The BayGenomics mouse (strain 129/Ola) ES cell line RRF047 was ob-
tained and conﬁ  rmed by RT-PCR. The gene trap vector (pGT2Lxf) was in-
serted in the   Cert   gene between exons 3 and 4 (26 kb). These cells were 
injected into C57BL/6 blastocysts, which were then implanted into pseudo-
pregnant foster mothers. High-contribution chimeras were obtained. Hetero-
zygous mice were backcrossed to C57BL/6 mice and kept in a 129/Ola 
cross C57BL/6 background. Therefore, all of the following experiments 
were performed with mice of the mixed genetic background. All mice were 
held in accordance with institutional policies and federal guidelines. 
  Mice were genotyped by a three-primer PCR using mouse tail DNA 
as a template. The primer sequences used were as follows: forward, 
5    -CTCATGATCATCGTGGTAGAGAGAC-3    ; mutant reverse, 5    -CCTA-
CATAGTTGGCAGTGTTTGGGG-3    ; and wild-type reverse, 5    -GTATGTT-
CAGGTAACTGTGGAGGC-3    . These primers ampliﬁ  ed bands of 319 bp 
and 481 bp for the mutant and wild-type allele, respectively. PCR reactions 
began with a denaturing step at 95  °  C for 3 min followed by 35 cycles of 
95  °  C for 30 s, 55  °  C for 30 s, and 72  °  C for 30 s. 
  Embryo dissection and histological and EM analyses 
  Timed mating was performed with   Cert 
+/gt     (+/    ) mice on a mixed genetic 
background (C57BL/J129). Females with copulation plugs were consid-
ered to be at day 0.5 of gestation, and embryos present in this pregnant 
female were designated at E0.5. Pregnant females were dissected at vari-
ous times of gestation, and the dissected embryos were photographed 
under a normal inverted light microscope (Axioskop; Carl Zeiss, Inc.) 
mitochondrial physiology (  Copeland and Dalton, 1959  ;   Ruby 
et al., 1969  ;   Morre et al., 1971  ;   Meier et al., 1978  ;   Eggens et al., 
1979  ;   Vance, 1991  ;   Rizzuto et al., 2004  ;   Franzini-Armstrong, 
2007  ). Several of these studies have even demonstrated a physi-
cal link between the ER and mitochondria. ER membranes 
called mitochondria-associated membranes are physically and 
functionally allied with mitochondria and have been implicated 
in the integration of several aspects of ER and mitochondrial 
function. Mitochondria-associated membranes are also involved 
in multiple mechanisms of the cooperative synthesis by the two 
organelles of the mitochondrial cytochrome   c   oxidase and phos-
pho- and glycerosphingolipids (  Shore and Tata, 1977  ;   Vance, 
1991  ;   van Meer and Lisman, 2002  ). A recent electron tomog-
raphy study demonstrated the existence of 10-nm and 25-nm 
tethers connecting smooth and rough ER, respectively, to mito-
chondria (  Csordas et al., 2006  ). Furthermore, although sphingo-
lipid levels are low in mitochondria, some enzymes involved in 
the de novo steps of the sphingolipid biosynthetic pathway, in-
cluding ceramide synthase and ceramidase, have been reported 
to localize to mitochondria (  Bionda et al., 2004  ). Our data sup-
port the idea that some mechanism exists for the transfer of cer-
amide from the ER to the mitochondria, either by physical 
continuity between the organelles or by a transfer protein. Al-
though delivering sphingolipid metabolites to the mitochondria 
may serve a useful function in healthy cells, it might also serve 
to mitigate the effect of the sphingolipids accumulating in the 
ER during stressful or pathological conditions. 
  In a recent study probing the mechanism of drug resis-
tance in tumor cells, it was shown that down-regulation of 
CERT sensitized these cells to the cytotoxic effects of paclitaxel 
and potentiated paclitaxel-induced ER stress (  Swanton et al., 
2007  ). However, in this study, we demonstrate that under physi-
ological conditions, in vivo loss of CERT induces a state of 
chronic stress in the ER and, most importantly, compromises 
mitochondrial structure and function. The state of chronic stress 
in CERT mutant embryos is comparable with that of cells that 
are exposed to chronic ER stress but that have adapted to the 
stress. In a study of different states of ER stress, cells exposed 
to low concentrations of tunicamycin showed UPR activation 
and ER perturbation, but the cells still proliferated, although at 
a slower rate than untreated cells, and did not show any signs of 
apoptosis (  Rutkowski et al., 2006  ). The chronically stressed 
cells achieved confl  uence and could be passaged for as long as 
their untreated counterparts (and they eventually achieved a 
near-normal growth rate) despite the continued presence of 
  tunicamycin in the culture. Thus, the decreased proliferation of 
the tunicamycin-treated cells was caused by a growth delay, and 
chronic ER stress by exogenous pharmacological manipulation 
does not necessarily result in cell death, although death could 
be caused by a secondary mitigating event. Similarly, physio-
logical activation of the UPR is observed in B lymphocytes as 
a result of increased demands of protein secretion (  Wu and 
Kaufman, 2006  ). 
  The lack of CERT function in mice did not result in cell 
death. The biochemical data suggest that the cells mounted an 
adaptation response to the ER and mitochondrial stress in the 
mutant embryos. Because CERT performs a fundamental func-155 MITOCHONDRIAL DYSFUNCTION IN CERT MUTANT MICE   • Wang et al. 
mitochondrial fractions were monitored by evaluating the ER resident 
protein BiP and mitochondrial marker protein Grp 75 in the preparations. 
There was   <  5% mixing of mitochondrial resident protein Grp 75 in ER 
preparation and, likewise,   <  1% of ER protein BiP in mitochondrial prepara-
tion (Fig. S1 C). 
  Sphingolipid standards were purchased from Sigma-Aldrich and 
Avanti Polar Lipids, Inc. The ceramide/sphingolipid internal standard 
mixture (LM6002), which contains a mixture of 10 sphingolipids, each 
present at a concentration of 25   μ  M, was purchased from Avanti Polar 
Lipids, Inc. 
  Primary MEF culture and cell death analysis 
  E9.5 embryos were separated from the yolk sac, washed twice with PBS, 
pH 7.2, and trypsinized for 10 min. The cells were disaggregated by pi-
petting several times and suspended in 1 ml of prewarmed (37  °  C) DMEM 
supplemented with 10% FBS. The suspension was allowed to stand for 2  –  3 min 
at room temperature, and visible clumps were removed. The suspension 
was further centrifuged at 500   g   for 3 min, and the cell pellet was sus-
pended in MEF media (DMEM + 10% FBS) and plated on a 48-well plate. 
The plates were incubated at 37  °  C with 3% oxygen and 5% carbon diox-
ide as described previously (  Parrinello et al., 2003  ). The medium was re-
placed the next day, and the cells were cultured for 4  –  5 d. For induction of 
apoptosis, the cells were treated with 10   μ  M actinomycin D for 12 h, after 
which the cell death was assessed using Vybrant apoptosis assay kit #2 
(Invitrogen) according to the manufacturer  ’  s instructions. The images were 
obtained on a microscope (Axioplan 2) at a magniﬁ  cation of 40 using 
Axiovision 4.2 (Carl Zeiss, Inc.) and pseudocolored using Photoshop 
(Adobe). For tabulation reported in Fig. S5, 68  –  218 cells were counted 
from three separate primary MEFs derived from   Cert 
+/+     E9.5 embryos, and 
between 52 and 157 cells were counted for three primary MEF lines de-
rived from E9.5   Cert 
gt/gt     embryos. 
  Sphingolipid estimation 
  Preparation of lipid extracts from tissues.     Lipid extracts were prepared, and 
sphingolipids were estimated according to the method described previ-
ously (  Han and Gross, 2005  ;   Merrill et al., 2005  ). In brief, to each of the 
50  –  100   μ  l of sample having a protein concentration of     3  –  4 mg/ml, 0.5 ml 
CH  3  OH, 0.25 ml CHCl  3  , 50  –  100   μ  l of water, and 30   μ  l of a 25-  μ  M solu-
tion of LM6002 internal standard were added. The lipid aggregates in the 
mixture were dispersed by either sonicating four times using a tip sonicator 
(Branson) at an amplitude of 30% for a period of 10 s or using a water 
bath sonicator for     15  –  30 min. After sonication, the samples were incu-
bated overnight at 48  °  C with shaking. After cooling, 75   μ  l of 1-M metha-
nolic KOH solution was added to each of the tubes followed by incubation 
at 37  °  C for 2 h with shaking. Each of the samples was then divided into 
two equal aliquots. 
  One of the aliquots was evaporated to a volume of     25   μ  l using a 
Speed Vac Concentrator (Savant Instruments, Inc.) and reconstituted with 
300  –  400   μ  l of 1:1 (vol/vol) reverse phase solution A and reverse phase 
solution B. After vortexing for 1 min and centrifugation, the supernatant 
was collected. 
  The other aliquot was neutralized by an addition of 3  –  4   μ  l 
CH  3  COOH followed by the addition of 2 ml of water and 1 ml CHCl  3  . The 
biphasic solution was vortexed for 1 min, and the lower organic phase 
was collected. This extraction procedure was repeated once more. The 
combined organic fractions were evaporated using a heating block set at 
50  °  C. Samples were reconstituted in 300  –  400   μ  l of 1:4 (vol/vol) CHCl  3    –
  nonpolar mobile phase solution A. Ceramides and sphingomyelins were 
analyzed from this solution by normal phase LC-MS. 
  Quantitation of ceramide and sphingomyelin molecular species by LC 
electrospray tandem MS.     LC-MS analyses were performed using a mass 
spectrometer (LTQ Discovery LC-MS; Thermo Electron Corp.) consisting of 
a Quantum triple stage quadrupole mass spectrometer equipped with an 
ESI source. The mass spectrometer was coupled to a high-performance LC 
system (1100 series; Agilent Technologies). 
  Complex sphingolipids (such as ceramides and sphingomyelins) 
were separated by normal phase high-performance LC using a binary sys-
tem and a Supelcosil LC-NH  2   column (internal diameter = 3.0 mm, length = 
7 cm, and mean particle size of the medium = 3   μ  m) operating at a ﬂ  ow 
rate of 250   μ  l/min. The column was maintained at 37  °  C. Mobile phase A 
consisted of 20 ml MeOH, 5 mM NH  4  OAc, 15 ml CH  3  COOH, 270 ml 
MeCN, 295 ml EtOAc, and 400 ml hexanes. Mobile phase B consisted of 
99:1 (vol/vol) CH  3  OH-CH  3  COOH containing 5 mM NH  4  OAc. The LC 
gradient run time for the analyses of ceramides and sphingomyelins was 
either 17 or 21 min. 
connected to a digital camera (Powershot S50; Canon), and DNA for geno-
typing was isolated from small pieces of yolk sac by hot-start PCR lysis 
buffer (25 mM NaOH and 0.2 mM EDTA) and neutralization buffer (40 mM 
Tris-HCl). Genotyping was performed by the aforementioned 3 primer hot 
short PCR. For histological analysis, embryos were ﬁ  xed with 4% parafor-
maldehyde (HCHO), embedded in parafﬁ  n, sectioned, and stained with 
hematoxylin and eosin (H  &  E). Photomicrographs were taken using a micro-
scope (Axiophot; Carl Zeiss, Inc.) and a digital camera (CoolSNAP HQ; 
Photometrics). For EM analysis, embryos were ﬁ  xed in 4% HCHO and 2% 
glutaraldehyde in 0.1 M sodium cacodylate buffer and processed as de-
scribed previously (  Acharya et al., 2006  ). Serial sections were viewed on 
an electron microscope (EM300; Philips Electronic Instruments, Inc.). 
  For blastocyst outgrowths, heterozygous 4  –  6-wk-old female mice 
were superovulated by intraperitoneal injection of a pregnant mare  ’  s serum 
(5 IU per animal) and human chorionic gonadotropin (5 IU per animal) 48 h 
later and were subsequently mated with   Cert 
+/gt     (+/    ) males. Plugged fe-
males were killed, and their uteri were dissected and ﬂ  ushed with ES cell 
medium at 3.5 d after coitus. Single blastocysts were seeded onto gelati-
nized 96-well plates containing 200   μ  l of medium and incubated at 37  °  C 
and 5% CO  2  . After 3 d, wash by PBS and blastocyst DNA was isolated by 
lysis buffer with proteinase K. The 3 primer PCR was performed. 
  LacZ staining was performed on E9.5 embryos dissected from the 
intercross of   Cert 
+/gt     in PBS, and embryos were transferred to 4% HCHO 
in PBS at 4  °  C and incubated in the dark for 1 h. Embryos were washed 
with rinse buffer (5 mM EGTA, 0.01% deoxycholate, 0.02% NP-40, and 
2 mM MgCl  2   in PBS) at room temperature three times for 15 min. The em-
bryos were incubated in the dark with freshly prepared staining buffer 
(5 mM K  3  Fe[CN]  6  , 5 mM K  4  Fe[CN]  6  , 5 mM EGTA, 0.01% deoxycholate, 
0.02% NP-40, 2 mM MgC1  2  , and 1 mg/ml X-gal solution in PBS) at 37  °  C 
overnight. Tissue sections were rinsed and stored in PBS and observed 
under a dissection microscope (Stemi DV4; Carl Zeiss, Inc.). 
  For BrdU, TUNEL staining, and immunohistochemistry, pregnant 
mice at E10.5 were injected intraperitoneally with BrdU (100 mg/kilo-
gram of body weight; Sigma-Aldrich) 1 h before the embryos were col-
lected. Embryos were isolated and ﬁ  xed in 10% formalin solution (neutral 
buffered; Sigma-Aldrich) and 70% ethanol, respectively, before histologi-
cal processing. Sagittal or transverse sectioning of samples embedded in 
optimal cutting temperature medium (Sakura Finetek) and immunohisto-
chemistry staining of the tissues or organs of the embryos were performed 
by the Pathology/Histotechnology Laboratory at the National Cancer Insti-
tute at Frederick. In brief, transverse and sagittal heart sections were 
stained with H  &  E. Embryo sections were stained with ApopTag kit (Milli-
pore) for apoptosis or antibodies against BrdU (Invitrogen) for proliferation 
according to the manufacturer  ’  s instructions. The slides were examined 
with a 5  ×  , 20  ×  , or 40  ×   lens (bright ﬁ  eld) under a microscope (Axioplan 2; 
Carl Zeiss, Inc.). 
  Subcellular fractionation for sphingolipid analysis and membrane 
ﬂ  uidity measurement 
  Plasma membrane was isolated by density gradient centrifugation, and 
membrane ﬂ  uidity was measured as described previously (  Eroglu et al., 
2003  ;   Rao et al., 2007  ). Embryos were washed thoroughly in PBS contain-
ing 0.5% Triton X-100 and were homogenized in homogenization buffer 
(100 mM Tris-HCl, pH 7.4, 150 mM sodium chloride, and 0.2 mM EGTA 
with protease inhibitor mixture). The homogenate was centrifuged at 1,000   g   
for 10 min to get rid of cell debris. The resulting postnuclear supernatant 
was mixed 1:2 with Opti-prep, resulting in a 40% solution. 30 and 5% 
Opti-prep solutions were overlaid on the top. The tubes were centrifuged 
for 3 h at 100,000   g  . Plasma membrane appeared as a white dense band 
at 30  –  5% interface. 
  Mitochondria and ER were isolated by following previously pub-
lished protocols with some modiﬁ  cations (  Bozidis et al., 2007  ). In brief, the 
embryos were homogenized in homogenization buffer A (20 mM Na-
Hepes, 0.1 mM EDTA, and 0.2 M sucrose) with protease inhibitors. The 
homogenate was centrifuged at 1,000   g   for 10 min, and the resulting su-
pernatant-I was carefully aspirated into a new tube and centrifuged at 
12,000   g   for 15 min. The pellet enriched in mitochondria was washed 
twice with the aforementioned buffer and used for cytochrome   c   oxidase 
assay. The supernatant-II (postmitochondrial supernatant) was centrifuged 
at 150,000   g   for 2 h, and the pellet was suspended in Hepes-EDTA buffer 
(20 mM Hepes and 0.1 mM EDTA) and loaded on top of the sucrose gradi-
ent tube (discontinuous gradient made with 2-, 1.5-, and 1.3-M sucrose so-
lutions in Hepes-EDTA buffer). The contents were centrifuged at 152,000   g   
for 70 min. The ER that appears as a band at the interface of the 1.3-M su-
crose gradient was collected into a new tube. The admixing of ER and JCB • VOLUME 184 • NUMBER 1 • 2009  156
mary antibodies. Positive antibody reactions were visualized with an HRP-
conjugated secondary antibody and a chemiluminescence detection system 
(PerkinElmer) according to the manufacturer  ’  s instruction. The membrane 
was deprobed and reprobed with an antiactin antibody to conﬁ  rm that all 
samples contained similar amounts of proteins. TTBS (TBS with 0.05% 
Tween 20) was used as a washing buffer, and 5% nonfat dry milk (Bio-Rad 
Laboratories) was dissolved in TTBS and used as a blocking solution. 
  RT-PCR analysis 
  Total RNA was extracted using the TRIZOL reagent (Invitrogen), and cDNAs 
were generated with reverse transcription (SuperScriptII; Invitrogen) ac-
cording to the manufacturer  ’  s instructions. 2   μ  l cDNA was ampliﬁ  ed in the 
PCR Master Mix solution (Promega). 
  Online supplemental material 
  Fig. S1 shows that the gene trap vector efﬁ  ciently traps the   Cert   gene. Fig. S2 
shows EM evidence of defects in the ER and mitochondria in cells from 
the developing embryonic optic cup of   Cert 
gt/gt     embryos. Fig. S3 shows 
that ER and mitochondrial defects can be noticed even at E9.5. Fig. S4 
shows that blastocysts from the preimplantation stage do not show gross 
abnormalities. Fig. S5 shows that   Cert 
gt/gt    -derived primary MEFs are capa-
ble of undergoing apoptosis. Videos 1 and 2 compare the cardiac output 
from E10.5 embryos of   Cert 
+/+     and   Cert 
gt/gt    , demonstrating the circulation 
defects in the mutant heart. Table S1 shows the detailed quantiﬁ  cation of 
the different species of sphingomyelin and ceramides estimated in the 
whole embryos and plasma membrane preparations of   Cert 
+/+     and   Cert 
gt/gt     
at E10.5. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200807176/DC1. 
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